痴呆症是我们"最大的扩大案例":学生语音和语言治疗师的核心学习
Anna Volkmer1, Reem S W Alyahya2, Hannah P Atkinson3
1Department of Psychology and Language Sciences, UCL, London, United Kingdom.
PloS one
|December 8, 2025
概括
语音和语言治疗的学生需要加强痴呆症培训. 该研究强调需要转变范式,重点关注以人为中心的护理和挑战刻板印象,以更好地支持不断增长的痴呆症人口.
科学领域:
- 语音和语言治疗治疗
- 老年学是一门学科.
- 医学教育 医学教育
背景情况:
- 痴呆症的患病率正在增加,影响了语言治疗师的角色.
- 对于学生语音和语言治疗师 (SLT) 在痴呆症方面的现有培训需要审查.
- 确保SLT专业人员能够满足不断扩大的痴呆症人口的需求至关重要.
研究的目的:
- 评估目前英国大学预注册学生SLT的痴呆症培训.
- 探索提供痴呆症培训的讲师的经验和观点.
- 为未来的SLTs确定痴呆教育的改进领域.
主要方法:
- 进行了一项解释性的顺序混合方法研究.
- 进行了一项调查,随后与参与者进行了两个焦点小组.
- 数据使用反射主题分析来分析.
主要成果:
- 六个关键主题出现了,包括痴呆症的复杂性,专业偏见和暴露对学生态度的影响.
- 建议的教学改进包括在整个课程中整合痴呆症主题.
- 在痴呆教育中强调以人为中心的护理被认为是必不可少的.
结论:
- 需要在SLT的痴呆教育中进行范式转变.
- 综合了有效的痴呆教学的五个核心组成部分:挑战刻板印象,专注于沟通,建立关系,设定目标和倡导高标准.
- 未来的研究应该涉及痴呆症患者,以完善这些教育组成部分.
更多相关视频
06:48Lexical Decision Task for Studying Written Word Recognition in Adults with and without Dementia or Mild Cognitive Impairment
Published on: June 25, 2019
9.7K
12:55Multimodal Protocol for Assessing Metacognition and Self-Regulation in Adults with Learning Difficulties
Published on: September 27, 2020
8.9K
相关概念视频
Learning Disabilities
550
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
Dyslexia
Dyslexia is a...
550
Dementia
487
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
487
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
2.3K
The nursing process provides a clinical decision-making framework for patients and families to establish and implement a personalized care plan. Since part of the nurse's duties is to teach patients, the steps of the nursing process are the most effective way to approach instruction. The nursing process and the teaching-learning process are inextricably linked.
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
2.3K
Cognitive Development During Adulthood
749
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
749
Alzheimer's Disease: Treatment
764
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
764
